Prevention of Ovarian Cancer: Where are We Now and Where are We Going?

Area of Science:

• Gynecologic Oncology
• Cancer Prevention Research
• Genetics and Genomics

Background:

• Ovarian cancer poses a significant health burden globally.
• Current prevention strategies, including screening and early detection, have not reduced mortality rates.
• Genetic testing identifies individuals at high risk, but current methods miss many.

Purpose of the Study:

• To outline current and future strategies for ovarian cancer prevention.
• To identify gaps in existing prevention methods.
• To propose a comprehensive approach to reduce ovarian cancer incidence and mortality.

Main Methods:

• Review of current genetic testing protocols and their limitations.
• Analysis of the efficacy of screening and early detection methods.
• Evaluation of surgical prevention options, including oophorectomy and salpingectomy.
• Exploration of novel molecular screening and early detection techniques.

Main Results:

• Genetic testing misses a substantial number of at-risk individuals, hindering prevention efforts.
• Screening and early detection have failed to decrease ovarian cancer mortality.
• Surgical prevention (oophorectomy) is effective but causes significant side effects (surgical menopause).
• Novel surgical approaches are being investigated to balance risk reduction and quality of life.

Conclusions:

• A multi-pronged approach is essential for maximizing ovarian cancer prevention.
• Future strategies should focus on more inclusive genetic testing to identify more at-risk individuals.
• Novel molecular screening and early detection methods are critically needed.
• Surgical prevention must prioritize quality of life alongside risk reduction.
• Wider adoption of targeted and opportunistic salpingectomy can contribute to reducing the ovarian cancer burden.